---
schema_version: "secwatch.filing_event.v1"
accession: "0001753926-24-000545"
form_type: "8-K"
ticker: "LIPO"
cik: "0001347242"
company_name: "LIPELLA PHARMACEUTICALS INC."
filed_at: "2024-03-15T23:59:59+00:00"
generated_at: "2026-06-04T16:53:46.636593+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# CEO and CMO each purchase $100k of Lipella common stock at $0.6901/share

## Summary
- CEO Jonathan Kaufman bought 144,906 shares for $100,000 at $0.6901/share on March 12, 2024.
- CMO Michael Chancellor bought 144,906 shares for $100,000 at same price and date.
- Total insider investment of $200,000; shares subject to six-month restricted period.
- Proceeds provide working capital; shares issued directly from company treasury.

## SEC filing metadata
- accession: 0001753926-24-000545
- form_type: 8-K
- ticker: LIPO
- cik: 0001347242
- company_name: LIPELLA PHARMACEUTICALS INC.
- filed_at: 2024-03-15T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1347242/000175392624000545/0001753926-24-000545-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1347242/000175392624000545/g084127_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001753926-24-000545
- JSON: https://secwatch.observer/filing/0001753926-24-000545.json
- Plain text: https://secwatch.observer/filing/0001753926-24-000545.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.